{
  "id": 13819694,
  "title": "Si-Bone director Jeffrey Dunn sells $369,400 in stock",
  "url": "https://urgent.news/2026/10/11/si-bone-director-jeffrey-dunn-sells-369-400-in-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-11T22:46:01.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/sibone-director-jeffrey-dunn-sells-369400-in-stock-93CH-4942874"
  },
  "original_language": "en",
  "account": "Jeffrey Dunn, a director at SI-BONE, Inc., sold 20,000 shares of the company's common stock for a total of $369,400 on October 1, 2026. The sale was made under a pre-arranged 10b5-1 trading plan and took place at prices ranging from $18.28 to $18.96 per share, with an average price of $18.47. The transaction occurred as SI-BONE stock had risen over 50% in the past six months, though analysis suggests the stock is currently overvalued. Simultaneously, Dunn acquired 20,000 shares through stock options, investing $93,600. After these activities, Dunn directly owns 16,057 shares, with 10,957 shares available upon settlement of restricted stock units, and an additional 81,073 shares held indirectly by The Jeffrey W. Dunn Living Trust. Dunn also possesses 66,260 stock options. SI-BONE reported strong second-quarter 2026 results, exceeding Wall Street expectations with an adjusted loss of $0.09 per share and revenue up 15.2% to $56 million. Canaccord Genuity maintained a Buy rating on the stock, targeting $27.00.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}